SPONSOR
AHS Cancer Control Alberta
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3
Conditions studied: Autologous Stem Cell TransplantGynecologic CancerAnemiaIron-deficiencyArthritisArthralgia
AHS Cancer Control Alberta is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Autologous Stem Cell Transplant, Gynecologic Cancer, Anemia, Iron-deficiency.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — AHS Cancer Control Alberta
How many clinical trials has AHS Cancer Control Alberta sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by AHS Cancer Control Alberta, of which 3 are actively recruiting participants. These trials cover conditions including Autologous Stem Cell Transplant, Gynecologic Cancer, Anemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does AHS Cancer Control Alberta research focus on?
AHS Cancer Control Alberta clinical trials span Autologous Stem Cell Transplant, Gynecologic Cancer, Anemia, Iron-deficiency, Arthritis, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a AHS Cancer Control Alberta clinical trial?
To participate in a AHS Cancer Control Alberta trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all AHS Cancer Control Alberta trials with current recruitment status updated daily.
Clinical Trials by AHS Cancer Control Alberta
NCT05358262 Phase 2
Recruiting
High Heated Humidity in Stem Cell Transplant
Autologous Stem Cell Transplant
NCT05407987 Phase 3
Recruiting
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Gynecologic Cancer
NCT04354649 Phase 2
Recruiting
Immune-Mediated Pathophysiology And Clinical Triage Program
Arthritis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology